<p>随着亚洲市场在主要指数表现不一的环境中航行，投资者越来越关注潜在增长的细分机会。便士股票通常与较小或较新的公司相关，由于其在稳健财务支持下的显著回报潜力，继续吸引关注。尽管这个术语已经过时，这些股票为发现被大型市场参与者忽视的优质公司的隐藏价值提供了独特机会。</p>
<h3>亚洲十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>回报与风险</strong></td>
</tr>
<tr>
<td>利华控股集团 (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>亚洲医学与农业实验室及研究中心 (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK 集团 (控股) (SEHK:2283)</td>
<td>HK$2.55</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>大西洋航运控股 (新加坡) (Catalist:5UL)</td>
<td>SGD0.108</td>
<td>SGD56.54M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>扬子江造船 (控股) (SGX:BS6)</td>
<td>SGD3.56</td>
<td>SGD14.01B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>安东油田服务集团 (SEHK:3337)</td>
<td>HK$0.79</td>
<td>HK$2.1B</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>娜迦控股 (SEHK:3918)</td>
<td>HK$4.81</td>
<td>HK$21.27B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>畜牧改良 (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>波司登国际控股 (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>斯科特科技 (NZSE:SCT)</td>
<td>NZ$2.88</td>
<td>NZ$237.99M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
<p>点击这里查看我们亚洲便士股票筛选器的完整列表，共 954 只股票。</p>
<p>让我们从我们的专业筛选器中发现一些宝藏。</p>
<h2>镍亚洲 (PSE:NIKL)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 镍亚洲公司在菲律宾运营，专注于镍沙岩、红土矿、石灰石和采石材料的开采与勘探，市值为₱61.58 亿。</p>
<p><strong>运营：</strong> 公司的收入主要来自其采矿业务，来自 TMC 的采矿收入为₱10.81 亿，来自 RTN 的采矿收入为₱7.87 亿，来自 HMC 的采矿收入为₱3.11 亿，以及来自 CMC 的采矿收入为₱3.49 亿；额外收入来自于电力生产，通过 EPI 的电力收入为₱1.03 亿和 NAC 的电力收入为₱212.40 万，以及 RTN/TMC/CDTN 提供的服务收入为₱1.03 亿。</p>
<p><strong>市值：</strong> ₱61.58B</p>
<p>镍亚洲公司市值为₱61.58 亿，最近显示出强劲的财务表现，与去年相比，报告了显著的收入和净收入增长。公司宣布将在 2025 年 12 月支付特别股息，表明其强大的现金流管理。尽管其债务在五年内有所增加，但仍然由运营现金流良好覆盖，并且有大量短期资产超过负债。然而，其盈利增长未能与更广泛的行业趋势相匹配，预测显示未来盈利可能下降。管理层正在进行变更，以潜在提升战略方向和治理稳定性。</p>
<ul>
<li>在我们的财务健康报告中更深入地了解镍亚洲的潜力。</li>
<li>查看我们的增长表现报告，以获取镍亚洲未来的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis"/></p>
<p>PSE:NIKL 债务与股本历史及分析截至 2026 年 1 月</p>
<h2>金海医疗科技 (SEHK:2225)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 金海医疗科技有限公司是一家投资控股公司，提供微创手术解决方案、医疗产品及相关服务，业务覆盖中华人民共和国和新加坡，市值为 HK$72.5 亿。</p>
<p><strong>运营：</strong> 公司的收入主要来自两个主要地区：新加坡贡献 SGD 14.82 百万，中华人民共和国贡献 SGD 19.83 百万。</p>
<p><strong>市值：</strong> HK$7.25B</p>
<p>尽管金海医疗科技市值为 HK$72.5 亿，但面临财务挑战，因其仍处于亏损状态，五年内亏损年增幅达到 83.8%。公司拥有 SGD 23.7 百万的短期资产，超过其短期和长期负债，显示出良好的流动性。尽管最近筹集资金以延长现金流动期超过初步三个月的预测，但净债务与股本比率为 16.5%，处于令人满意的水平。管理层和董事会成员经验丰富，平均任期分别为 4.3 年和 6.5 年，为在持续的财务困难中提供稳定性。</p>
<ul>
<li>通过我们的综合资产负债表健康报告深入了解金海医疗科技的复杂性。</li>
<li>通过检查我们的业绩历史报告了解金海医疗科技的业绩记录。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis"/></p>
<p>SEHK:2225 财务状况分析截至 2026 年 1 月</p>
<h2>扬子江金融控股 (SGX:YF8)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 扬子江金融控股有限公司是一家投资控股公司，涉及中国和新加坡的投资相关活动，市值为 SGD1.41 亿。</p>
<p><strong>运营：</strong> 该公司从其投资业务部门产生 SGD288.47 百万的收入。</p>
<p><strong>市值：</strong> SGD1.41B</p>
<p>扬子江金融控股有限公司市值为 14.1 亿新加坡元，财务状况良好，其 22 亿新加坡元的短期资产显著超过短期和长期负债，并且公司无债务。尽管过去一年盈利增长了 128.4%，但未来三年预计年均盈利将下降 5.7%。公司的股票交易价格显著低于估计的公允价值，但近期股价波动性较大。最近的高管变动包括在战略分拆决策后对关键职位的新任命，暗示公司方向可能发生变化。</p>
<ul>
<li>点击这里访问我们完整的财务健康分析报告，以了解扬子江金融控股的动态。</li>
<li>在这里了解扬子江金融控股的未来增长轨迹。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 1 月 SGX:YF8 的债务与股本历史及分析</p>
<h2>接下来该如何？</h2>
<ul>
<li>点击这里解锁我们 954 只亚洲便士股票的综合列表。</li>
<li>准备好采取不同的方法了吗？特朗普承诺将 “释放” 美国的石油和天然气，这 22 只美国股票的发展有望受益。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

利华控股集团

<p>随着亚洲市场表现不一，投资者正将目光投向低价股以寻求潜在增长。这些与小型公司相关的股票提供了显著回报的机会。值得一提的公司包括利华控股集团、亚洲医疗与农业实验室以及尽管债务增加但财务表现强劲的镍亚洲公司。金海医疗科技面临盈利挑战，而扬子江金融控股则展现出强健的财务状况，但预计未来收益将下降。总体而言，亚洲的低价股市场为寻求隐藏价值的投资者提供了风险与回报并存的机会</p>

<p>As the Asian markets navigate a landscape marked by mixed performances in key indices, investors are increasingly looking toward niche opportunities for potential growth. Penny stocks, often associated with smaller or newer companies, continue to capture attention due to their potential for significant returns when backed by solid financials. Despite being an outdated term, these stocks provide a unique opportunity for discovering hidden value in quality companies that might be overlooked by larger market players.</p>
<div class="lb-trans"><p>随着亚洲市场在主要指数表现不一的环境中航行，投资者越来越关注潜在增长的细分机会。便士股票通常与较小或较新的公司相关，由于其在稳健财务支持下的显著回报潜力，继续吸引关注。尽管这个术语已经过时，这些股票为发现被大型市场参与者忽视的优质公司的隐藏价值提供了独特机会。</p>
</div><h3>Top 10 Penny Stocks In Asia</h3>
<div class="lb-trans"><h3>亚洲十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.55</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.108</td>
<td>SGD56.54M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.56</td>
<td>SGD14.01B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Anton Oilfield Services Group (SEHK:3337)</td>
<td>HK$0.79</td>
<td>HK$2.1B</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.81</td>
<td>HK$21.27B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Scott Technology (NZSE:SCT)</td>
<td>NZ$2.88</td>
<td>NZ$237.99M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>回报与风险</strong></td>
</tr>
<tr>
<td>利华控股集团 (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>亚洲医学与农业实验室及研究中心 (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK 集团 (控股) (SEHK:2283)</td>
<td>HK$2.55</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>大西洋航运控股 (新加坡) (Catalist:5UL)</td>
<td>SGD0.108</td>
<td>SGD56.54M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>扬子江造船 (控股) (SGX:BS6)</td>
<td>SGD3.56</td>
<td>SGD14.01B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>安东油田服务集团 (SEHK:3337)</td>
<td>HK$0.79</td>
<td>HK$2.1B</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>娜迦控股 (SEHK:3918)</td>
<td>HK$4.81</td>
<td>HK$21.27B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>畜牧改良 (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>波司登国际控股 (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>斯科特科技 (NZSE:SCT)</td>
<td>NZ$2.88</td>
<td>NZ$237.99M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 954 stocks from our Asian Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们亚洲便士股票筛选器的完整列表，共 954 只股票。</p>
</div><p>Let's uncover some gems from our specialized screener.</p>
<div class="lb-trans"><p>让我们从我们的专业筛选器中发现一些宝藏。</p>
</div><h2>Nickel Asia (PSE:NIKL)</h2>
<div class="lb-trans"><h2>镍亚洲 (PSE:NIKL)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Nickel Asia Corporation operates in the Philippines, focusing on the mining and exploration of nickel saprolite, limonite ore, limestone, and quarry materials with a market capitalization of ₱61.58 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 镍亚洲公司在菲律宾运营，专注于镍沙岩、红土矿、石灰石和采石材料的开采与勘探，市值为₱61.58 亿。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its mining operations, with significant contributions from Mining - TMC (₱10.81 billion), Mining - RTN (₱7.87 billion), Mining - HMC (₱3.11 billion), and Mining - CMC (₱3.49 billion); additional income comes from power generation through Power - EPI (₱1.03 billion) and Power - NAC (₱212.40 million), as well as services provided by RTN/TMC/CDTN amounting to ₱1.03 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其采矿业务，来自 TMC 的采矿收入为₱10.81 亿，来自 RTN 的采矿收入为₱7.87 亿，来自 HMC 的采矿收入为₱3.11 亿，以及来自 CMC 的采矿收入为₱3.49 亿；额外收入来自于电力生产，通过 EPI 的电力收入为₱1.03 亿和 NAC 的电力收入为₱212.40 万，以及 RTN/TMC/CDTN 提供的服务收入为₱1.03 亿。</p>
</div><p><strong>Market Cap:</strong> ₱61.58B</p>
<div class="lb-trans"><p><strong>市值：</strong> ₱61.58B</p>
</div><p>Nickel Asia Corporation, with a market cap of ₱61.58 billion, has shown robust financial performance recently, reporting significant revenue and net income growth compared to the previous year. The company declared special dividends payable in December 2025, indicating strong cash flow management. Despite its debt increasing over five years, it remains well-covered by operating cash flow and is supported by substantial short-term assets exceeding liabilities. However, its earnings growth doesn't match the broader industry trends and forecasts suggest a potential decline in future earnings. Management changes are underway to potentially enhance strategic direction and governance stability.</p>
<div class="lb-trans"><p>镍亚洲公司市值为₱61.58 亿，最近显示出强劲的财务表现，与去年相比，报告了显著的收入和净收入增长。公司宣布将在 2025 年 12 月支付特别股息，表明其强大的现金流管理。尽管其债务在五年内有所增加，但仍然由运营现金流良好覆盖，并且有大量短期资产超过负债。然而，其盈利增长未能与更广泛的行业趋势相匹配，预测显示未来盈利可能下降。管理层正在进行变更，以潜在提升战略方向和治理稳定性。</p>
</div><ul>
<li>Take a closer look at Nickel Asia's potential here in our financial health report.</li>
<li>Review our growth performance report to gain insights into Nickel Asia's future.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的财务健康报告中更深入地了解镍亚洲的潜力。</li>
<li>查看我们的增长表现报告，以获取镍亚洲未来的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis"/></p>
<p>PSE:NIKL Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>PSE:NIKL 债务与股本历史及分析截至 2026 年 1 月</p>
</div><h2>Jinhai Medical Technology (SEHK:2225)</h2>
<div class="lb-trans"><h2>金海医疗科技 (SEHK:2225)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Jinhai Medical Technology Limited is an investment holding company that offers minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore, with a market cap of HK$7.25 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 金海医疗科技有限公司是一家投资控股公司，提供微创手术解决方案、医疗产品及相关服务，业务覆盖中华人民共和国和新加坡，市值为 HK$72.5 亿。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from two primary regions: Singapore, contributing SGD 14.82 million, and the People's Republic of China, accounting for SGD 19.83 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自两个主要地区：新加坡贡献 SGD 14.82 百万，中华人民共和国贡献 SGD 19.83 百万。</p>
</div><p><strong>Market Cap:</strong> HK$7.25B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$7.25B</p>
</div><p>Jinhai Medical Technology faces financial challenges despite its HK$7.25 billion market cap, as it remains unprofitable with losses increasing by 83.8% annually over five years. The company has short-term assets of SGD 23.7 million exceeding both its short and long-term liabilities, indicating a solid liquidity position. Although it recently raised capital to extend its cash runway beyond the initial three months forecast, the net debt to equity ratio is satisfactory at 16.5%. Management and board members bring experience with average tenures of 4.3 and 6.5 years respectively, providing stability amid ongoing financial hurdles.</p>
<div class="lb-trans"><p>尽管金海医疗科技市值为 HK$72.5 亿，但面临财务挑战，因其仍处于亏损状态，五年内亏损年增幅达到 83.8%。公司拥有 SGD 23.7 百万的短期资产，超过其短期和长期负债，显示出良好的流动性。尽管最近筹集资金以延长现金流动期超过初步三个月的预测，但净债务与股本比率为 16.5%，处于令人满意的水平。管理层和董事会成员经验丰富，平均任期分别为 4.3 年和 6.5 年，为在持续的财务困难中提供稳定性。</p>
</div><ul>
<li>Navigate through the intricacies of Jinhai Medical Technology with our comprehensive balance sheet health report here.</li>
<li>Understand Jinhai Medical Technology's track record by examining our performance history report.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过我们的综合资产负债表健康报告深入了解金海医疗科技的复杂性。</li>
<li>通过检查我们的业绩历史报告了解金海医疗科技的业绩记录。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis"/></p>
<p>SEHK:2225 Financial Position Analysis as at Jan 2026</p>
<div class="lb-trans"><p>SEHK:2225 财务状况分析截至 2026 年 1 月</p>
</div><h2>Yangzijiang Financial Holding (SGX:YF8)</h2>
<div class="lb-trans"><h2>扬子江金融控股 (SGX:YF8)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Yangzijiang Financial Holding Ltd. is an investment holding company involved in investment-related activities in China and Singapore, with a market cap of SGD1.41 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 扬子江金融控股有限公司是一家投资控股公司，涉及中国和新加坡的投资相关活动，市值为 SGD1.41 亿。</p>
</div><p><strong>Operations:</strong> The company generates revenue of SGD288.47 million from its investment business segment.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司从其投资业务部门产生 SGD288.47 百万的收入。</p>
</div><p><strong>Market Cap:</strong> SGD1.41B</p>
<div class="lb-trans"><p><strong>市值：</strong> SGD1.41B</p>
</div><p>Yangzijiang Financial Holding Ltd., with a market cap of SGD1.41 billion, shows strong financial health as its short-term assets of SGD2.2 billion surpass both short and long-term liabilities significantly, and it operates debt-free. Despite earnings growth of 128.4% over the past year, future earnings are expected to decline by an average of 5.7% annually over the next three years. The company's stock trades at a significant discount to estimated fair value, but high volatility persists in its share price recently. Recent executive changes include new appointments in key positions following a strategic spin-off decision, suggesting potential shifts in company direction.</p>
<div class="lb-trans"><p>扬子江金融控股有限公司市值为 14.1 亿新加坡元，财务状况良好，其 22 亿新加坡元的短期资产显著超过短期和长期负债，并且公司无债务。尽管过去一年盈利增长了 128.4%，但未来三年预计年均盈利将下降 5.7%。公司的股票交易价格显著低于估计的公允价值，但近期股价波动性较大。最近的高管变动包括在战略分拆决策后对关键职位的新任命，暗示公司方向可能发生变化。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of Yangzijiang Financial Holding.</li>
<li>Learn about Yangzijiang Financial Holding's future growth trajectory here.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们完整的财务健康分析报告，以了解扬子江金融控股的动态。</li>
<li>在这里了解扬子江金融控股的未来增长轨迹。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis"/></p>
<p>SGX:YF8 Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月 SGX:YF8 的债务与股本历史及分析</p>
</div><h2>Where To Now?</h2>
<div class="lb-trans"><h2>接下来该如何？</h2>
</div><ul>
<li>Unlock our comprehensive list of 954 Asian Penny Stocks by clicking here.</li>
<li>Ready For A Different Approach? Trump has pledged to &#34;unleash&#34; American oil and gas and these 22 US stocks have developments that are poised to benefit.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里解锁我们 954 只亚洲便士股票的综合列表。</li>
<li>准备好采取不同的方法了吗？特朗普承诺将 “释放” 美国的石油和天然气，这 22 只美国股票的发展有望受益。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

亚洲市场亮点：2026 年 1 月值得关注的低价股